Eye Center, Second Affiliated Hospital of Medical College, Zhejiang University, Hangzhou, Zhejiang, China.
Key Laboratory of Ophthalmology of Zhejiang Province, Hangzhou, China.
Sci Rep. 2017 Apr 27;7(1):1219. doi: 10.1038/s41598-017-01182-9.
Congenital cataract is the most frequent inherited ocular disorder and the most leading cause of lifelong visual loss. The screening of pathogenic mutations can be very challenging in some cases, for congenital cataracts are clinically and genetically heterogeneous diseases. The aim of this study is to investigate the mutation spectrum and frequency of 54 cartaract-associated genes in 27 Chinese families with congenital cataracts. Variants in 54 cataract-associated genes were screened by targeted next-generation sequencing (NGS) and then validated by Sanger sequencing. We identified pathogenic variants in 62.96% (17/27) of families, and over 52.94% (9/17) of these variants were novel. Among them, three are splicing site mutations, four are nonsense mutations, seven are missense mutations, two are frame shift mutations and one is intronic mutation. This included identification of: complex ocular phenotypes due to two novel PAX6 mutations; progressive cortical cataract and lamellar cataract with lens subluxation due to two novel CRYGS mutations. Mutations were also found in rarely reported genes including CRYBA4, CRYBA2, BFSP1, VIM, HSF4, and EZR. Our study expands the mutation spectrum and frequency of genes responsible for congenital cataracts. Targeted next-generation sequencing in inherited congenital cataract patients provided significant diagnostic information.
先天性白内障是最常见的遗传性眼部疾病,也是导致终身视力丧失的主要原因。在某些情况下,对致病突变的筛查可能极具挑战性,因为先天性白内障是具有临床和遗传异质性的疾病。本研究旨在调查 54 个与白内障相关基因在 27 个先天性白内障中国家系中的突变谱和频率。通过靶向下一代测序(NGS)筛选 54 个白内障相关基因的变异,然后通过 Sanger 测序进行验证。我们在 62.96%(17/27)的家庭中发现了致病性变异,其中超过 52.94%(9/17)的变异是新的。其中,三个是剪接位点突变,四个是无义突变,七个是错义突变,两个是移码突变,一个是内含子突变。这包括两个新的 PAX6 突变导致的复杂眼部表型;两个新的 CRYGS 突变导致进行性皮质白内障和板层白内障伴晶状体脱位。在很少报道的基因中也发现了突变,包括 CRYBA4、CRYBA2、BFSP1、VIM、HSF4 和 EZR。本研究扩展了导致先天性白内障的基因突变谱和频率。对遗传性先天性白内障患者进行靶向下一代测序提供了重要的诊断信息。